Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, the IND hold has been ongoing. They still have not dented the "lengthy list" they need to potentially have the hold lifted.
This company is just a slush fund to pad the portfolios of aging execs.
The lengthy list creates pump PR's that are completely meaningless but create an appearance that something is being done.
There are no medical cures here. It's not that the technology is antiquated which it is. It's that the "snake in the box" technology never really had value.
Gene editing is the future of biotech not "leach in a box"
They need to pivot to Ascites (again) to act like something is actually going on, which it isn't.
This press releases is right out of 2016
They know the LAPC IND will never get accepted so they pivot too ascites once again.
Look at the five year chart of the share price, tells the story.
From KW on November 4, 2020:
"PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, said, “Our team of experts is developing action plans to address the clinical hold letter. Since the FDA’s letter included a lengthy list of items and several preclinical studies, at this time it’s impossible to say when the company will be in a position to submit a complete response to the FDA. One big reason for the uncertainty is because some of the preclinical studies will be performed by outside third-party laboratories. Also, we are planning to request a meeting with the FDA about some of its requests. So, this is currently a very fluid situation.”
The actual "lengthy list" giving to pmcb seems to have disappeared from the PharmaCyte website. They do not want transparency. They want false hope.
I believe the FDA rejected PMCB's request for another meeting. They want nothing to do with Leech in a Box.
In September it will be two years since the IND submission.
Gene therapies are passing this technology bye.
Aging execs playing off investor false hopes.
Pmcb, soon to be delisted.
I am embarrassed I fell for this at one time. I truly am and should be.
I will not sit by and watch others get scammed
Look at the five year chart.
Look at the press releases and the bungling over time.
The company is run by a penny stock lawyer with past legal issues.
This is not an investment at all. The FDA is not interested.
If you want a biotech moonshot buy one of the gene editing stocks, that is your shot not weasel in a box.
Hopefully this scam is about to fully unravel, and none else will get hurt. pmcb
Thank You, I needed a good laugh so bad. Appreciate it.
PMCB not curing anything
They are going to Barcelona, LOL
Now that's accelerating.
PMCB is just too funny.
I am amused
Look at pmcb's five year chart and then run do not walk from this scam.
This is a company designed to pad the portfolios of aging execs.
No medical cures here, just a nice gig for a few old men.
"PharmaCyte Biotech to Accelerate Preparations for Start of Pancreatic Cancer Clinical Trial"
I see now they are accelerating, What have they been doing for the past 6 years. Definitely not accelerating. Good word accelerating, wonderfully vague and promising. Great pump verbiage.
I see Lohr is now on the board, he needs his portfolio padded as well. What happened to the other Dr. Is he about to join the board too.
This is a train wreck for investors. Look at the 5 year chart of the share price.
PMCB on the verge? Link please
Investors, Pmcb is a company that does not act in good faith. This is the last place to put your investment dollar. Do a five year chart of share price, then invest anywhere but here. It is that bad.
Good Morning Astra!
I agree, I like KW much more than Putin. PMCB lol
The stock is up today.
Who is buying this PMCB garbage?
I feel sorry for them. Oh well, what can you do?
Kursplat.
Thats is some very helpful due diligence on PMCB.
The five year chart is also interesting.
Can we go sub penny again after a huge reverse split?
Yup
I think if Putin invades Ukraine, that would be enough to get it back to sub penny. Imagine after that HUGE reverse split and this thing goes sub penny again.
These guys at PMCB really no how to make investment dollars disappear.
Is PMCB worth a dollar?
"several others are quite lengthy and are underway or are slated to begin soon."
Isn't that convenient for those who get paid.
Lengthy tests, press releases that suggest progress, and high salaries for years to come.
Buying more in the 4s. Thank You to all those who sold.
Perfect, plenty of time to get that "lengthy list" accomplished. I hope it happens for you all.
Let's say August 1 as a deadline. About 161 days. seems fair
"KW said we should be done with all that was asked for by the FDA by the end of this 1/4."
Well then, let's start a countdown. According to KW the IND will be lifted at then end of the first quarter.
Looks to be about 71 days. Let the countdown begin. Deep guttural laughter.
I have been here long enough to know that the IND will never be lifted.
A penny stock lawyer with no medical background is going to save the medical world?
I would invest in Gene Editing if you are looking for a multi bagger.
I learned a hard lesson here, don't let that happen to you.
Pre recorded? Unbelievable. KW hides again. Is it that he cannot explain the technology enough? Does KW not want to answer questions as usual? Or does he no darn well snake in a box is an outdated unproven treatment nobody wants.
Gene editing is a medical revolution. Snake in a box is for padding the portfolios of old executives.
RUN!
Hopefully he will do a better job than The Big Biz Show disaster. That was a horrible.
Remember, penny stock lawyer not in the medical field, and it shows.
PMCB pumps
A prosperous New Year to all PMCB people.
Will the following NASDAQ rule come into play with PMCB in 2022? Likely.
"The stock can sell for under $1 a share for 29 consecutive trading days and still be safe from delisting. However, it must sell for $1 or more on day 30."
I said it would take years to complete the FDA's lengthy list associated with PMCB's failed IND.
-We are well into year two, not much has been accomplished.
Completing the list will probably never happen, and provides no Guarantee the IND will ever be lifted.
GENE EDITING is the future of medicine not Snake in a Box.
The good news is PMCB execs will continue to collect huge salaries at share holders expense.
PMCB's five year chart = disaster.
The CEO has no medical background, he is a penny stock lawyer who has a shady past with other companies.
Can the recycled press releases keep this company(?) above a dollar in 2022? I doubt it.
Who is buying today in the 7s besides me?
Their tax sale is my gain.
I wonder where the stock price is in February?
Happy New Year to all.
Adding more NIO
Too much good news on expansion.
Hey Vane, Check out the five years chart for PMCB, Quite revealing.
Hello Vane, welcome to the board.
I do have a masters degree in Science. I am no expert on Biotech.
I have been trading stocks for forty years.
Did I mention I taught at the University level.
I am free to have my opinion. Good luck in your investment in PMCB
Even ViaCyte realizes that gene editing is the future, not Snake in a box.
"The development of VCTX210 by CRISPR and ViaCyte is part of a strategic collaboration agreement between the two companies to co-develop and co-commercialize gene-editing allogenic cell stem therapies for the treatment of diabetes. VCTX210 is the first therapy under the collaboration to enter clinical studies.
The therapies under this collaboration utilize the combination of CRISPR’s gene-editing technology and ViaCyte’s proprietary stem cell capabilities."
https://finance.yahoo.com/news/crispr-crsp-begin-clinical-study-154503569.html
PMCB treatments are not viable. Is Snake in a box really going to compete with this?
People, look at the five year chart and the past press releases. None of this will ever change.
This is a Biotech? company run by a penny stock lawyer?.
The company is designed to sell shares and pay huge salaries and nothing more.
Gene editing is the future of medicine not Snake in a Box.
RUN TO ANY OTHER INVESTMENT, RUN!
One opinion from a guy who learned a tough lesson here about investment scams.
Lurking in the weeds. Waiting for the huge down day for the markets, then adding.
Sold 80% of my shares at 40. Took profits and kept free shares.
The time to reload is approaching. Good luck all
The FDA provided KW with a "lengthy List" of things to do so there is still plenty of time to collect grossly oversized salaries.
Check out the five year chart.
Very entertaining press release today. They are really knocking off the items on that "lengthy list". We should be able to submit our IND paperwork by 2040 easy at this pace.
Do not fall for something that sounds important when it is a drop in the bucket.
This "lengthy list" will linger for a long time.
Gene editing is the future not Leech in a box.
David Judd from Thermo Fisher got a good look at PMCB.
Thermo Fisher grows their company by acquiring other companies.
They showed no interest because they know what the future of medicine is.
Awesome post for bulls. Holding some shares here.
It is too early in the EV game to announce winners yet.
Peter Beck, Rocket Lab CEO:" Not reusing rockets is a dead-end product"
Sounds like the rocket lab CEO is afraid of something.
My guess is Rocket lab can't afford to have disposable rockets because they put so much money into making them. Even the retrieval cost money.
"Rocket Lab’s approach to recovering its Electron booster is to guide it back through the atmosphere and deploy a parachute. The company would then use a helicopter to snag the parachute above the ocean and carry the booster back to land."
Well that's sounds easy. Must be a heck of a helicopter. Helicopters and helicopter fuel are not cheap.
I think NASA scrapped this idea in the 60s. JK
It will be interesting to see how this plays out. I like ASTRA's plan better. Thats why I am here.
I fell for the PMCB scam personally. I admit it.
I have been here for five years. Look at the five year chart.
They have been telling us the trial is about to start since I have been here.
Their IND was put on hold. The list to lift the hold is long and comes with no guarantee the hold will ever be lifted..
The longer the list, the more time to run the scam and receive huge compensation at shareholders expense.
Constantly rehashing old press releases and ensnaring new victims as they sell shares and pad their portfolios.
The future of medicine is gene editing not leech in a box.
No anger here, just a lesson well learned.
Run from this company!
Wow, PMCB and ascites again. I think this is the third time they have pivoted to ascites. Rinse, repeat.
These prices are an absolute gift.
Astra has the best BUSINESS plan of all rocket companies.
We are down today which is a joke. We are going to make real money here.
We are in early in a great company. The space industry is in its embryonic stage.
This will blow up as launches keep increasing in frequency.